USE OF IMIDAZOPYRIMIDINES OR IMIDAZOTRIAZINES FOR PREVENTING, RELIEVING OR TREATING COGNITIVE IMPAIRMENT, OR FOR IMPROVING COGNITIVE FUNCTION Russian patent published in 2025 - IPC A61K31/519 A61K31/53 A61K45/08 A61P25/28

Abstract RU 2835510 C1

FIELD: pharmaceutics.

SUBSTANCE: group of inventions relates to the field of pharmaceutics, namely to a method for preventing, relieving or treating cognitive impairment, or improving cognitive function in a subject, and to the use of a compound of a defined structure for preventing, relieving or treating cognitive impairment, or for improving cognitive function. Method of preventing, relieving or treating cognitive impairment, or improving cognitive function in a subject, which involves administering to a subject a therapeutically effective amount of 6-[4-fluoro-2-(trifluoromethyl)phenyl]-2-(2-pyridyloxymethyl)imidazo[1,2-a]pyrimidine or a pharmaceutically acceptable salt, solvate or hydrate thereof. Use of 6-[4-fluoro-2-(trifluoromethyl)phenyl]-2-(2-pyridyloxymethyl)imidazo[1,2-a]pyrimidine or a pharmaceutically acceptable salt, solvate or hydrate thereof for preventing, relieving or treating cognitive impairment, or to improve cognitive function.

EFFECT: said group of inventions enables to effectively prevent, relieve or treat cognitive disorders and improve cognitive function.

18 cl, 4 dwg, 4 tbl, 3 ex

Similar patents RU2835510C1

Title	Year	Author	Number
IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVE	2016	Park, Chun Eung Jang, Young Koo Shin, Yong Je Kim, Ji Yeon Ham, Seung Mo Kim, Yong Gil Min, Hye Kyung Cha, Soo Bong Jung, Hyo Jun Lee, Ju Young Han, Seung Nam Chung, Jin Yong Choi, Eun Ju Joung, Chan Mi Park, Jong Sil Lee, Ji Won Cho, Nahm Ryune Ryu, Eun Ju Maeng, Cheol Young	RU2710556C2
METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS	2012	Gallagher, Michela Haberman, Rebecca Koh, Ming Teng	RU2792010C2
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS	2012	Gallakher Mikhela Khaberman Rebekka Kokh Min Ten	RU2665021C2
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS	2011	Uolkenberg Skott Berrou Dzhejms K. Poslasni Majkl S. Kharrison Skott T. Trotter B. Uesli Malkhirn Dzhejms Nanda Kausik K. Menli Piter Dzh. Chzhao Chzhitszyan Shubert Dzheffri V. Kett Natan Zartman Emi	RU2586974C2
ORGANIC COMPOUNDS	2014	Li Pen Chzhen Khajlin Chzhao Tszyun Uennogl Lourens	RU2679142C2
FLUORINATED LIGANDS FOR TARGETING PERIPHERAL BENZODIAZEPINE RECEPTORS	2007	Katsifis Ehndrju Fuks Kristofer Dzhon Redzhinal'D Fam Tien Kuok Gregurik Ivan Damir Mattner Marija Filomena Perejra Soares	RU2468014C2
IMIDAZOTRIAZINONE COMPOUNDS	2011	Ripka Emi Shapiro Gideon Makrajner Endrju	RU2603140C2
2-ARYLIMIDAZO[1,2-b]PYRIDAZINE,2-PHENYLIMIDAZO[1,2-a]PYRIDINE AND 2-PHENYLIMIDAZO[1,2-a]PYRAZINE DERIVATIVES	2011	Etkinson Robert N. Ommen Endi Dzh. Vil Dzhejms M. Khuan Kennet Kh. Smit Emili D.	RU2598385C2
2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDRO-1H-[1,2-A]-PYRAZINE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF BINDING DOPAMINE WITH DOPAMINE D RECEPTOR	1995	Kishor A. Desaj Ehnton F. Dzh. Fliri Mark A. Sehnner	RU2163239C2
USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE	2014	Okumura Takako	RU2663620C2

RU 2 835 510 C1

Authors

Dzong, Chan Mi

Chung, Dzin Jong

Dates

2025-02-26—Published

2020-10-21—Filed